Brian O’Mahony

2.0k total citations
87 papers, 1.3k citations indexed

About

Brian O’Mahony is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Brian O’Mahony has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Brian O’Mahony's work include Hemophilia Treatment and Research (68 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Brian O’Mahony is often cited by papers focused on Hemophilia Treatment and Research (68 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Brian O’Mahony collaborates with scholars based in Ireland, United Kingdom and United States. Brian O’Mahony's co-authors include Declan Noone, Mark W. Skinner, Lucia Prihodová, Diane J. Nugent, G. Dolan, Paul Giangrande, Michael Makris, Alfonso Iorio, Jamie O’Hara and Claudia Black and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brian O’Mahony

85 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian O’Mahony Ireland 21 1.0k 171 151 130 124 87 1.3k
Nico van der Lely Netherlands 17 270 0.3× 43 0.3× 151 1.0× 34 0.3× 65 0.5× 59 705
Tom Burke United Kingdom 12 292 0.3× 38 0.2× 35 0.2× 57 0.4× 28 0.2× 52 631
Shiraz R. Gupta United States 15 107 0.1× 65 0.4× 61 0.4× 29 0.2× 33 0.3× 20 1.2k
Bruno Horisberger Switzerland 14 269 0.3× 49 0.3× 109 0.7× 92 0.7× 17 0.1× 36 955
I. Gilloteau United States 18 160 0.2× 53 0.3× 200 1.3× 59 0.5× 21 0.2× 48 998
Liza Takiya United States 15 137 0.1× 19 0.1× 51 0.3× 70 0.5× 25 0.2× 47 888
Lisa M. Holle United States 16 80 0.1× 60 0.4× 135 0.9× 30 0.2× 19 0.2× 33 679
E. A. Lyons United States 8 171 0.2× 46 0.3× 106 0.7× 30 0.2× 26 0.2× 15 549
K Malottki United Kingdom 11 77 0.1× 50 0.3× 59 0.4× 45 0.3× 34 0.3× 17 725
Allison Streetly United Kingdom 13 383 0.4× 26 0.2× 69 0.5× 500 3.8× 34 0.3× 26 778

Countries citing papers authored by Brian O’Mahony

Since Specialization
Citations

This map shows the geographic impact of Brian O’Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian O’Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian O’Mahony more than expected).

Fields of papers citing papers by Brian O’Mahony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian O’Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian O’Mahony. The network helps show where Brian O’Mahony may publish in the future.

Co-authorship network of co-authors of Brian O’Mahony

This figure shows the co-authorship network connecting the top 25 collaborators of Brian O’Mahony. A scholar is included among the top collaborators of Brian O’Mahony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian O’Mahony. Brian O’Mahony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Mahony, Brian, Níall Lally, Andrew O’Malley, et al.. (2025). Novel substance, same old problems: admissions of psychosis precipitated by hexahydrocannabinol, a widely available semi-synthetic cannabinoid. BJPsych Bulletin. 50(2). 132–137. 1 indexed citations
2.
O’Mahony, Brian, et al.. (2024). HHC-induced psychosis: a case series of psychotic illness triggered by a widely available semisynthetic cannabinoid. Irish Journal of Psychological Medicine. 41(3). 405–408. 12 indexed citations
3.
Curtis, Randall, Joanne Wu, Alfonso Iorio, et al.. (2024). Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study. Haemophilia. 30(3). 702–708. 1 indexed citations
4.
5.
6.
O’Mahony, Brian, Glenn Nielsen, Sallie Baxendale, Mark J. Edwards, & Mahinda Yogarajah. (2023). Economic Cost of Functional Neurologic Disorders. Neurology. 101(2). e202–e214. 37 indexed citations
7.
Kaczmarek, Radosław, Glenn F. Pierce, Declan Noone, et al.. (2023). Hemophilia gene therapy: first, do no harm. Journal of Thrombosis and Haemostasis. 21(9). 2354–2361. 11 indexed citations
8.
Kaczmarek, Radosław, Magdy El Ekiaby, Daniel P. Hart, et al.. (2021). Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 27(4). 515–518. 6 indexed citations
9.
Stonebraker, Jeffrey S., Brian O’Mahony, Declan Noone, & Alfonso Iorio. (2021). Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time. Haemophilia. 27(5). e596–e608. 4 indexed citations
10.
Bullinger, Monika, Hannah B Lewis, Wolfgang Miesbach, et al.. (2021). The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia. SHILAP Revista de lepidopterología. 8(1). 56–68. 4 indexed citations
11.
O’Hara, Jamie, Antony P. Martin, Diane J. Nugent, et al.. (2021). Evidence of a disability paradox in patient‐reported outcomes in haemophilia. Haemophilia. 27(2). 245–252. 33 indexed citations
12.
Stonebraker, Jeffrey S., Paula Bolton‐Maggs, Mark Brooker, et al.. (2020). The World Federation of Hemophilia Annual Global Survey 1999‐2018. Haemophilia. 26(4). 591–600. 74 indexed citations
13.
Pierce, Glenn F., Radosław Kaczmarek, Declan Noone, et al.. (2020). Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?. Haemophilia. 26(6). 931–933. 19 indexed citations
14.
Konkle, Barbara A., Donna Coffin, Lindsey A. George, et al.. (2020). Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18(11). 3074–3077. 35 indexed citations
15.
Chai‐Adisaksopha, Chatree, Declan Noone, Randall Curtis, et al.. (2020). Non‐severe haemophilia: Is it benign? – Insights from the PROBE study. Haemophilia. 27(S1). 17–24. 25 indexed citations
16.
Chai‐Adisaksopha, Chatree, Mark W. Skinner, Randall Curtis, et al.. (2018). Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. BMJ Open. 8(8). e021900–e021900. 19 indexed citations
17.
18.
Colvin, B T, G. Dolan, Carlo Martinoli, & Brian O’Mahony. (2013). Pfizer‐sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia. European Journal Of Haematology. 90(s73). 1–9. 2 indexed citations
19.
O’Mahony, Brian. (1999). Irish health care Web sites: a review.. PubMed. 92(4). 334–7. 6 indexed citations
20.
O’Mahony, Brian, et al.. (1996). Keeping up to date--a challenge for teaching practices.. PubMed. 88(5). 170–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nico van der Lely Breakdown of academic impact, for papers by Tom Burke Breakdown of academic impact, for papers by Shiraz R. Gupta Breakdown of academic impact, for papers by Bruno Horisberger Breakdown of academic impact, for papers by I. Gilloteau Breakdown of academic impact, for papers by Liza Takiya Breakdown of academic impact, for papers by Lisa M. Holle Breakdown of academic impact, for papers by E. A. Lyons Breakdown of academic impact, for papers by K Malottki Breakdown of academic impact, for papers by Allison Streetly
Rankless by CCL
2026